Bioventix (BVXP) Stock Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, the United Kingdom.

BVXP Stock Information

Symbol

BVXP

Address

7 Romans Business ParkFarnham, GU9 7SXUnited Kingdom

Founded

Trading hours

8:00 AM - 4:30 PM GMT

Website

https://www.bioventix.com

Country

🇬🇧 United Kingdom

Phone Number

44 12 5272 8001

Bioventix (BVXP) Price Chart

Bioventix Overview: Key Details and Summary

Stock data	2023	Change
Price	$56.11	N/A
Market Cap	$292.48M	N/A
Shares Outstanding	5.21M	0.06%
Employees	12.00	N/A
Shareholder Equity	12.06M	2.05%

Valuation	2023	Change
P/E Ratio	35.45	N/A
P/S Ratio	17.39	N/A
P/B Ratio	24.24	N/A

Growth	2023	Change
Return on Equity	0.9110	N/A

Earnings	2023	Change
Revenue	$16.82M	N/A
Earnings	$10.99M	N/A
EPS	1.58	N/A
Earnings Yield	0.0282	N/A
Gross Margin	0.9354	N/A
Operating Margin	0.7857	N/A
Net income margin	0.6533	N/A

Financial Strength	2023	Change
Total Assets	$17.43M	N/A
Cash on Hand	$7.50M	N/A
Debt to Equity	0.1325	-7.94%
Current Ratio	$10.08	6.87%